Global Iron Drugs Market 2018-2022

Below are some of the key findings from the iron drugs market research report

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.

Get a FREE sample now!

Global iron drugs industry overview

A key factor driving the market’s growth is the growing demand for non-dextran IV iron drugs. Several IV iron complexes are available for the treatment of iron deficiency anemia. Iron dextran is associated with a high risk of anaphylactic reactions, whereas others must be administered in numerous small infusions to avoid labile iron reactions. The demand has shifted from conventional dextran IV iron drugs to non-dextran IV iron drugs.

The vendor focus on expanding the reach of IV iron drugs is identified as one of the key emerging trends in the global iron drugs market. Vendors are focusing on strategies to expand the reach and scope of IV iron drugs. For instance, a major vendor is looking to consolidate its presence in the market by expanding the reach of its flagship IV iron drug. The number of units sold of the flagship IV iron drug increased significantly across the world in 2015. This was because of the strong demand in Australia, Germany, Spain, the Nordic countries, the UK, and Ireland. Several companies are strengthening their position by conducting disease awareness programs, clinical trials, and medical education support for physicians. One of the research products is the study on people with chronic heart failure and iron deficiency. Such initiatives will increase the adoption of iron drugs in the forecast period. Factors like these are anticipated to propel the market to grow at a CAGR of over 9% during the forecast period.

Top iron drugs companies covered in this market research report

The iron drugs market is fairly concentrated. By offering a complete analysis of the market’s competitive landscape and with information on the products offered by the companies, this iron drugs industry analysis report will aid clients to identify new growth opportunities and plan better business strategies.

The report offers a complete analysis of various companies including:

• Allergan
• AMAG Pharmaceuticals
• Daiichi Sankyo
• PHARMACOSMOS
• Vifor Pharma

Iron drugs market segmentation based on geographic regions

• Americas
• APAC
• EMEA

With a complete study of the growth opportunities for the companies, the Americas will account for the highest growth of this market throughout the forecast period. The Americas held the highest share of the global iron drugs market in 2017, accounting for a market share of approximately 44%. This region is anticipated to dominate the global market throughout the period 2018-2022.

Iron drugs market segmentation based on products

• Oral drug
• IV drug

The oral drug segment will account for the highest growth in the market. The oral drug segment held the largest iron drugs market share in 2017, accounting for more than 52% of the market Additionally, the report also provides an accurate prediction of the contribution of the various products segments to the growth of the iron drugs market size.

Key highlights of the global iron drugs market for the forecast years 2018-2022:

• CAGR of the market during the forecast period 2018-2022
• Detailed information on factors that will accelerate the growth of the iron drugs market during the next five years
• Precise estimation of the global iron drugs market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the iron drugs industry across the Americas, APAC, and EMEA
• A thorough analysis of the market’s competitive landscape and detailed information on several vendors
• Comprehensive details on the factors that will challenge the growth of iron drugs companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch